Details of the Drug

General Information of Drug (ID: DMSJWTE)

Drug Name
OKI 179
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Drug Type
Small molecular drug
Cross-matching ID
DrugBank ID
DB17583
TTD ID
DZU72C

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Histone deacetylase (HDAC) TTBH0VX NOUNIPROTAC Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03931681) A Study of OKI-179 in Patients With Solid Tumors. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of OnKure Therapeutics.